Back to TNXP
CITADEL ADVISORS LLC TNXP Position History
Tonix Pharmaceuticals Holding Corp. • Healthcare
Quarters held
16
Latest value
$189K
Q3 2026
Peak value
$6.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $84K |
| Q2 2025 | $171K |
| Q4 2025 | $622K |
| Q1 2026 | $6.3M |
| Q1 2026 | $353K |
| Q1 2026 | $100K |
| Q1 2026 | $239K |
| Q2 2026 | $2.5M |
| Q2 2026 | $587K |
| Q2 2026 | $577K |
| Q2 2026 | $2.5M |
| Q2 2026 | $587K |
| Q2 2026 | $577K |
| Q3 2026 | $3.1M |
| Q3 2026 | $355K |
| Q3 2026 | $189K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $189K | 19.4K | — | — |
| Q3 2026 | $355K | 36.4K | — | — |
| Q3 2026 | $3.1M | 318.0K | — | — |
| Q2 2026 | $577K | 45.2K | — | — |
| Q2 2026 | $587K | 46.0K | — | — |
| Q2 2026 | $2.5M | 195.9K | — | — |
| Q2 2026 | $577K | 45.2K | — | — |
| Q2 2026 | $587K | 46.0K | — | — |
| Q2 2026 | $2.5M | 195.9K | — | — |
| Q1 2026 | $239K | 17.4K | — | — |
| Q1 2026 | $100K | 7.3K | — | — |
| Q1 2026 | $353K | 25.7K | — | — |
| Q1 2026 | $6.3M | 461.4K | — | — |
| Q4 2025 | $622K | 39.8K | — | — |
| Q2 2025 | $171K | 4.7K | — | — |
| Q2 2025 | $84K | 2.3K | — | — |